Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Fellendorf, FT; Hamm, C; Platzer, M; Lenger, M; Dalkner, N; Bengesser, SA; Birner, A; Queissner, R; Sattler, M; Pilz, R; Kapfhammer, HP; Lackner, HK; van, Poppel, M; Reininghaus, E.
[Symptom Monitoring and Detection of Early Warning Signs in Bipolar Episodes Via App - Views of Patients and Relatives on e-Health Need].
Fortschr Neurol Psychiatr. 2022; 90(6):268-279
Doi: 10.1055/a-1503-4986
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Fellendorf Frederike
- Hamm Carlo
- Co-Autor*innen der Med Uni Graz
- Bengesser Susanne
- Birner Armin
- Dalkner Nina
- Kapfhammer Hans-Peter
- Lackner Helmut Karl
- Lenger Melanie
- Pilz Rene
- Platzer Martina
- Queissner Robert
- Reininghaus Eva
- Van Poppel Mireille Nicoline Maria
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: The onset and early warning signs of episodes of bipolar disorder are often realized late by those affected. The earlier an incipient episode is treated, the more prognostically favorable the course will be. Symptom monitoring via smartphone application (app) could be an innovative way to recognize and react to early warning signs more swiftly. The aim of this study was to find out whether patients and their relatives consider technical support through an app to be useful and practical in the early warning sign detection and treatment. METHODS: In the present study, 51 patients with bipolar disorder and 28 relatives were interviewed. We gathered information on whether participants were able to perceive early warning signs in form of behavioral changes sufficiently and in a timely fashion and also whether they would use an app as treatment support tool. RESULTS: Although 94.1% of the surveyed patients and 78.6% of their relatives felt that they were well informed about the disease, 13.7% and 35.7%, respectively were not fully satisfied with the current treatment options. Early warning signs of every depressive development were noticed by 25.5% of the patients (relatives 10.7%). Every (hypo)manic development was only noticed by 11.8% of the patients (relatives 7.1%); 88.2% of the patients and 85.7% of the relatives noticed the same symptoms recurrently at the beginning of a depression and 70.6% and 67.9%, respectively, at the beginning of a (hypo)manic episode (in particular changes in physical activity, communication behavior and the sleep-wake rhythm). 84.3% of the patients and 89.3% of the relatives stated that they considered technical support that draws attention to mood and activity changes as useful and that they would use such an app for the treatment. DISCUSSION: The current options for perceiving early warning signs of a depressive or (hypo)manic episode in bipolar disorder are clinically inadequate. Those affected and their relatives desire innovative, technical support. Early detection of symptoms, which often manifest themselves in changes in behavior or activity patterns, is essentiell for managing the course of bipolar disorder. In the future, smartphone apps could be used for clinical treatment and research through objective, continuous and.
- Find related publications in this database (using NLM MeSH Indexing)
- Bipolar Disorder - diagnosis, drug therapy
- Emotions - administration & dosage
- Humans - administration & dosage
- Mania - administration & dosage
- Mobile Applications - administration & dosage
- Telemedicine - administration & dosage
- Find related publications in this database (Keywords)
- mobile health
- bipolar disorder
- smartphone app
- symptom monitoring
- early warning signs